Drugs / RO6889678
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02321384 | Dec 2014 → Nov 2015 | — | Hoffmann-La Roche | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO6889678 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321384 ↗ |
| Route | Oral | “RO6889678 will be administered orally” NCT02321384 ↗ |